Nov. 14 at 8:46 AM
$SBFM G'day All! Well, firstly let me get my commiserations out of the way to that very special breed of perma bear ("PB"). The PBs are no doubt bitterly disappointed following the ER that SBFM is still growing, now has 76 drugs in its portfolio with more to follow, still has
$9 million in the bank, still has net assets of
$24 million (3 times its current market cap), has effected no big cash raise, has seen no effective short activity, no mass dumping of shares, no decline below
$1 and no reverse stock split. This was not the armegeddon that you PBs know, love and are praying for.
Far from it. I was very reassured by the ER. This is a business which is maturing, has a clear vision and plan and is working its way towards that. The revenue trajectory is in-line with what Slialty predicated at the start of the year (which, at that time led to the usual, *yawn*, accusations of 'pumping'). Admitedly, the ER was not a breakthrough moment but I, for one, will continue to hold.
